Journal Watch - Hemodialysis

« Back to Most Recent

  1. Cost Effectiveness: Conventional vs. High Dose HD

    An analysis of seven studies of high dose HD found that it is cost effective when delivered at home.

    Read the abstract » | (added 01/10/2016)

    Tags: Hemodialysis

  2. NxStage and 2008K@Home Head-to-Head

    Compared to NxStage users, those who dialyzed on a 2008K@Home did fewer treatments per week but had significantly higher standardized weekly Kt/V’s. NxStage users tended to use less ESA medication. No differences were found in other parameters, including levels of albumin, calcium, phosphorus, PTH, or in hospital stays.

    Read the abstract » | (added 01/10/2016)

    Tags: Hemodialysis

  3. Why Do People Stop Doing Home HD?

    Among 2,840 people who started home HD between 2007 and 2009, nearly one in four stopped within a year, while 1-year mortality was 7.6%. The risks of stopping home HD were higher among those with diabetes, and substance use (alcohol, tobacco, drugs). Those who were listed for transplant or lived in rural areas were less likely to stop home HD.

    Read the abstract » | (added 01/10/2016)

    Tags: Hemodialysis

  4. Nanomembranes for Miniature HD

    Dialyzors with membranes that are more permeable could be much smaller—in fact, small enough for wearable dialysis. Ultra-thin silicon may be a candidate, and a prototype miniature membrane is predicted to clear toxins at “near-ideal levels.”

    Read the abstract » | (added 01/10/2016)

    Tags: Hemodialysis